← All trials
NCT06575075
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2024
- Primary completion
- Nov 30, 2028
- Completion date
- Nov 30, 2029
- First posted
- Aug 28, 2024
- Last posted
- Aug 28, 2024
- Enrollment
- 45
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Stanford UniversityLead sponsor
- Stanford UniversitySponsor investigator
- Stanford UniversityOfficial
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.